AI assistant
Orchid Pharma Limited — M&A Activity 2025
Aug 5, 2025
60526_rns_2025-08-05_e8469dfe-2211-485d-b9e1-1c8701769d0f.pdf
M&A Activity
Open in viewerOpens in your device viewer
August 05, 2025
==> picture [587 x 69] intentionally omitted <==
National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai-400051
Phiroze Jeejeebhoy Towers Dalal Street, Fort, Mumbai-400001
Symbol: ORCHPHARMA
Scrip Code: 524372
Ref: Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015
Sub: Update on purchase of Assets of Allecra Therapeutics SAS
Dear Sir/Madam,
In continuation to our earlier intimation dated July 30, 2025 regarding Purchase of Assets of Allecra Therapeutics SAS, we would like to inform you that today the Hon’ble Court of France has pronounced the order in favour of Orchid Pharma Limited, to acquire the assets of Allecra Therapeutics SAS with effect from August 01, 2025.
We request you to take the above intimation on records.
Thanking You, For Orchid Pharma Limited
KAPIL Digitally signed by KAPIL DAYYA DAYYA Date: 2025.08.05 21:21:38 +05'30'
Kapil Dayya Company Secretary & Compliance Officer Membership No.: F10698
==> picture [552 x 13] intentionally omitted <==
Orchid Pharma Limited Regd. Office: Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Alathur, Chengalpattu Dist.- 603110, Tamil Nadu, India